Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
3 trials since 2013, 3 ongoing, by the sponsor of the products; see every authorized trial
A phase 1/2, first-in-human, dose escalation and expansion study to evaluate the safety, tolerability, and efficacy of…Jul 15, 2026 · Ongoing · VV-14300 / Actemra / Avtozma / Tyenne
A phase 1/2, first-in-human, multi-arm, dose-escalation study to evaluate the safety, tolerability, and efficacy of an…Nov 8, 2024 · Ongoing · VV-14295 / Durezol / Prednisolone / Prednisone
A phase 1/2, multicenter, open-label study to evaluate the safety, tolerability, and preliminary efficacy of…Mar 31, 2023 · Ongoing · RP-008 / Varenicline / Prednisone / Prednisolone sodium phosphate
Orphan designations (FDA)
One designation since 1983, 0 approved for the designated use, matched by the sponsor's name; see all orphan designations
AAV2.adalimumabTreatment of non-infectious intermediate, posterior, or panuveitis or chronic non-infectious… · Jun 22, 2022
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.